Clinical Trial Update: LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rivaroxaban for antithrombotic prevention in hypertrophic cardiomyopathy patients with abnormal left atrial strain; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Rennes University Hospital | Conditions: Hypertrophic Cardiomyopathy (HCM) | Phase 3 | Status: NOT_YET_RECRUITING